Bridgeway Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $225K | Buy |
29,700
+10,000
| +51% | +$75.6K | 0.01% | 936 |
|
|
2025
Q1 | $109K | Sell |
19,700
-26,500
| -57% | -$146K | ﹤0.01% | 1024 |
|
|
2024
Q4 | $266K | Sell |
46,200
-1,800
| -4% | -$10.4K | 0.01% | 950 |
|
|
2024
Q3 | $497K | Buy |
+48,000
| New | +$497K | 0.01% | 862 |
|
|
2018
Q4 | – | Sell |
-26,600
| Closed | -$2.27M | – | 1396 |
|
|
2018
Q3 | $2.27M | Buy |
26,600
+2,800
| +12% | +$239K | 0.02% | 578 |
|
|
2018
Q2 | $2.76M | Buy |
23,800
+600
| +3% | +$69.5K | 0.03% | 507 |
|
|
2018
Q1 | $1.88M | Sell |
23,200
-250
| -1% | -$20.2K | 0.02% | 615 |
|
|
2017
Q4 | $1.38M | Buy |
+23,450
| New | +$1.38M | 0.01% | 711 |
|
|
2017
Q3 | – | Sell |
-20,000
| Closed | -$720K | – | 1414 |
|
|
2017
Q2 | $720K | Hold |
20,000
| – | – | 0.01% | 960 |
|
|
2017
Q1 | $616K | Hold |
20,000
| – | – | 0.01% | 991 |
|
|
2016
Q4 | $670K | Hold |
20,000
| – | – | 0.01% | 960 |
|
|
2016
Q3 | $532K | Hold |
20,000
| – | – | 0.01% | 1072 |
|
|
2016
Q2 | $441K | Hold |
20,000
| – | – | 0.01% | 1096 |
|
|
2016
Q1 | $587K | Hold |
20,000
| – | – | 0.01% | 976 |
|
|
2015
Q4 | $660K | Buy |
+20,000
| New | +$660K | 0.01% | 946 |
|